{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:16Z","timestamp":1792182316196,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"\u00a72 Abs. 3 Kooperationsvertrag","award":["project no. 3\/2014"],"award-info":[{"award-number":["project no. 3\/2014"]}]},{"name":"\u00a72 Abs. 3 Kooperationsvertrag","award":["project no. 3\/2014"],"award-info":[{"award-number":["project no. 3\/2014"]}]},{"DOI":"10.13039\/100009103","name":"Von-Behring-R\u00f6ntgen-Stiftung","doi-asserted-by":"publisher","award":["project no. 60-0038"],"award-info":[{"award-number":["project no. 60-0038"]}],"id":[{"id":"10.13039\/100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009103","name":"Von-Behring-R\u00f6ntgen-Stiftung","doi-asserted-by":"publisher","award":["project no. 60-0038"],"award-info":[{"award-number":["project no. 60-0038"]}],"id":[{"id":"10.13039\/100009103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13287-017-0553-y","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T08:23:33Z","timestamp":1493195013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid"],"prefix":"10.1186","volume":"8","author":[{"given":"Madeleine C.","family":"Killer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Nold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Henkenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Riedlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Barckhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Hackstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"553_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"553_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17:11\u201322.","journal-title":"Cell Stem Cell"},{"key":"553_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.imlet.2015.05.017","volume":"168","author":"A Tyndall","year":"2015","unstructured":"Tyndall A. Mesenchymal stromal cells and rheumatic disorders. Immunol Lett. 2015;168:201\u20137.","journal-title":"Immunol Lett"},{"key":"553_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2012.10.010","volume":"149","author":"MM Zafranskaya","year":"2013","unstructured":"Zafranskaya MM, Nizheharodova DB, Yurkevich MY, Lamouskaya NV, Motuzova YM, Bagatka SS, Ivanchik HI, Fedulov AS. In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients. Immunol Lett. 2013;149:9\u201318.","journal-title":"Immunol Lett"},{"key":"553_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Blanc Le","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringd\u00e9n O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579\u201386.","journal-title":"Lancet"},{"key":"553_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13577-014-0095-x","volume":"27","author":"B Amorin","year":"2014","unstructured":"Amorin B, Alegretti AP, Valim V, Pezzi A, Laureano AM, da Silva MAL, Wieck A, Silla L. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell. 2014;27:137\u201350.","journal-title":"Hum Cell"},{"key":"553_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.5966\/sctm.2015-0021","volume":"4","author":"OE Simonson","year":"2015","unstructured":"Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dal\u00e9n M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OPB, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson P-O, H\u00e4gglund H, Mattsson M, Lehti\u00f6 J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo K-H, Le Blanc K. In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl Med. 2015;4:1199\u2013213.","journal-title":"Stem Cells Transl Med"},{"key":"553_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","volume":"15","author":"P Kebriaei","year":"2009","unstructured":"Kebriaei P, Isola L, Bahceci E, Holland K, Rowley S, McGuirk J, Devetten M, Jansen J, Herzig R, Schuster M, Monroy R, Uberti J. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15:804\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"key":"553_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/bmt.2008.316","volume":"43","author":"M Bonin von","year":"2009","unstructured":"von Bonin M, St\u00f6lzel F, Goedecke A, Richter K, Wuschek N, H\u00f6lig K, Platzbecker U, Illmer T, Schaich M, Schetelig J, Kiani A, Ordemann R, Ehninger G, Schmitz M, Bornh\u00e4user M. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009;43:245\u201351.","journal-title":"Bone Marrow Transplant"},{"key":"553_CR10","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/j.bbmt.2009.12.057","volume":"16","author":"PJ Martin","year":"2010","unstructured":"Martin PJ, Uberti JP, Soiffer RJ, Klingemann H, Waller EK, Daly AS, Herrmann RP, Kebriaei P. Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD. Biol Blood Marrow Transplant. 2010;16:S169\u201370.","journal-title":"Biol Blood Marrow Transplant"},{"key":"553_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bbrc.2012.11.001","volume":"430","author":"P Nold","year":"2013","unstructured":"Nold P, Brendel C, Neubauer A, Bein G, Hackstein H. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor. Biochem Biophys Res Commun. 2013;430:325\u201330.","journal-title":"Biochem Biophys Res Commun"},{"key":"553_CR12","doi-asserted-by":"publisher","unstructured":"Rojewski MT, Fekete N, Baila S, Nguyen K, F\u00fcrst D, Antwiler D, Dausend J, Kreja L, Ignatius A, Senseb\u00e9 L, Schrezenmeier H. GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system. Cell Transplant. 2013;22:1981\u20132000. doi:\n10.3727\/096368912X657990\n\n.","DOI":"10.3727\/096368912X657990"},{"key":"553_CR13","first-page":"193519","volume":"2010","author":"K Bieback","year":"2011","unstructured":"Bieback K, Kinzebach S, Karagianni M. Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int. 2011;2010:193519.","journal-title":"Stem Cells Int"},{"issue":"October","key":"553_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jcyt.2014.10.004","volume":"17","author":"P Nold","year":"2015","unstructured":"Nold P, Hackstein H, Riedlinger T, Kasper C, Neumann A, Mernberger M, F\u00f6lsch C, Schmitt JAN, Fuchs-winkelmann S, Barckhausen C, Killer M, Neubauer A, Brendel C. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation. J Cytotherapy. 2015;17(October):152\u201362.","journal-title":"J Cytotherapy"},{"key":"553_CR15","doi-asserted-by":"publisher","unstructured":"Wuchter P, Bieback K, Schrezenmeier H, Bornh\u00e4user M, M\u00fcller LP, B\u00f6nig H, Wagner W, Meisel R, Pavel P, Tonn T, Lang P, M\u00fcller I, Renner M, Malcherek G, Saffrich R, Buss EC, Horn P, Rojewski M, Schmitt A, Ho AD, Sanzenbacher R, Schmitt M. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications. Cytotherapy. 2015;17:128\u201339. doi:\n10.1016\/j.jcyt.2014.04.002\n\n.","DOI":"10.1016\/j.jcyt.2014.04.002"},{"key":"553_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/14653249.2011.623691","volume":"14","author":"M Fran\u00e7ois","year":"2012","unstructured":"Fran\u00e7ois M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-\u03b3 licensing. Cytotherapy. 2012;14:147\u201352.","journal-title":"Cytotherapy"},{"key":"553_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","volume":"15","author":"J Galipeau","year":"2013","unstructured":"Galipeau J. The mesenchymal stromal cells dilemma\u2014does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy. 2013;15:2\u20138.","journal-title":"Cytotherapy"},{"key":"553_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"553_CR19","doi-asserted-by":"publisher","unstructured":"Capasso S, Alessio N, Squillaro T, Di Bernardo G, Melone MA, Cipollaro M, Peluso G, Galderisi U. Changes in autophagy, proteasome activity and metabolism to determine a specific signature for acute and chronic senescent mesenchymal stromal cells. Oncotarget. 2015;6. doi:\n10.18632\/oncotarget.6277\n\n. Link to Pubmed: \nhttps:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4741838\/\n\n.","DOI":"10.18632\/oncotarget.6277"},{"key":"553_CR20","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/stem.1729","volume":"32","author":"G Moll","year":"2014","unstructured":"Moll G, Alm JJ, Davies LC, von Bahr L, Heldring N, Stenbeck-Funke L, Hamad OA, Hinsch R, Ignatowicz L, Locke M, L\u00f6nnies H, Lambris JD, Teramura Y, Nilsson-Ekdahl K, Nilsson B, Le Blanc K. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells. 2014;32:2430\u201342.","journal-title":"Stem Cells"},{"key":"553_CR21","doi-asserted-by":"publisher","unstructured":"Cho G, Kang BY, Kim K-S, Kim SH. Effects of valproic acid on the expression of trophic factors in human bone marrow mesenchymal stromal cells. Neurosci Lett. 2012;526:100\u20135. doi:\n10.1016\/j.neulet.2012.08.015\n\n.","DOI":"10.1016\/j.neulet.2012.08.015"},{"key":"553_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","volume":"57","author":"K Blanc Le","year":"2003","unstructured":"Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringd\u00e9n O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11\u201320.","journal-title":"Scand J Immunol"},{"key":"553_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jcyt.2014.10.002","volume":"17","author":"DD Bloom","year":"2015","unstructured":"Bloom DD, Centanni JM, Bhatia N, Emler CA, Drier D, Leverson GE, McKenna DH, Gee AP, Lindblad R, Hei DJ, Hematti P. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. Cytotherapy. 2015;17:140\u201351.","journal-title":"Cytotherapy"},{"key":"553_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13287-015-0233-8","volume":"6","author":"N Ketterl","year":"2015","unstructured":"Ketterl N, Brachtl G, Schuh C, Bieback K, Schallmoser K, Reinisch A, Strunk D. A robust potency assay highlights significant donor variation of human mesenchymal stem\/progenitor cell immune modulatory capacity and extended radio-resistance. Stem Cell Res Ther. 2015;6:236.","journal-title":"Stem Cell Res Ther"},{"key":"553_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.autrev.2013.09.007","volume":"13","author":"E Ben-Ami","year":"2014","unstructured":"Ben-Ami E, Miller A, Berrih-Aknin S. T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: role of IL-2. Autoimmun Rev. 2014;13:187\u201396.","journal-title":"Autoimmun Rev"},{"key":"553_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/btpr.2034","volume":"31","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ma T. Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application. Biotechnol Prog. 2014;31:468\u201381.","journal-title":"Biotechnol Prog"},{"key":"553_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cryobiol.2015.07.003","volume":"71","author":"LA Marquez-Curtis","year":"2015","unstructured":"Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JAW. Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology. 2015;71:181\u201397.","journal-title":"Cryobiology"},{"key":"553_CR28","doi-asserted-by":"publisher","first-page":"28656","DOI":"10.1074\/jbc.M112.356584","volume":"287","author":"J Lv","year":"2012","unstructured":"Lv J, Du C, Wei W, Wu Z, Zhao G, Li Z, Xie X. The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis. J Biol Chem. 2012;287:28656\u201365.","journal-title":"J Biol Chem"},{"key":"553_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2119\/molmed.2011.00007","volume":"17","author":"S Choi","year":"2011","unstructured":"Choi S, Reddy P. HDAC inhibition and graft versus host disease. Mol Med. 2011;17:404\u201316.","journal-title":"Mol Med"},{"key":"553_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yexmp.2009.06.003","volume":"87","author":"SJ Saouaf","year":"2009","unstructured":"Saouaf SJ, Li B, Zhang G, Shen Y, Furuuchi N, Hancock WW, Greene MI. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis. Exp Mol Pathol. 2009;87:99\u2013104.","journal-title":"Exp Mol Pathol"},{"key":"553_CR31","doi-asserted-by":"publisher","unstructured":"Yang H, Sun J, Wang F, Li Y, Bi J, Qu T. Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture\u2014a preliminary study. Oncotarget. 2016. doi:\n10.18632\/oncotarget.12345\n\n. Link to Pubmed: \nhttps:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5341927\/\n\n.","DOI":"10.18632\/oncotarget.12345"},{"key":"553_CR32","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1089\/scd.2014.0564","volume":"24","author":"A Becker De","year":"2015","unstructured":"De Becker A, Van Riet I. Mesenchymal stromal cell therapy in hematology: from laboratory to clinic and back again. Stem Cells Dev. 2015;24:1713\u201329.","journal-title":"Stem Cells Dev"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-017-0553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T08:23:40Z","timestamp":1493195020000},"score":1,"resource":{"primary":{"URL":"http:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-017-0553-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1186\/s13287-017-0553-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"article-number":"100"}}